Jonathan Hirsch

Jonathan Hirsch

Syapse

About

Role

Founder and President

Type

Full-time operator, Angel

Bio

Jonathan Hirsch is the founder of Syapse, a market leader in precision medicine solutions. Jonathan founded Syapse in 2008, and helped establish the industry verticals for precision medicine and real world evidence in oncology. Jonathan works closely with healthcare providers, life sciences companies, molecular diagnostics labs, and government agencies to create products that improve patient outcomes through precision medicine. Before founding Syapse, Jonathan worked in neuroscience commercial development at Abbott Laboratories (now AbbVie). Jonathan received an MSci in Neuroscience from Stanford University and an AB in Biology and Political Philosophy from the University of Chicago. He is affiliated with several funds, including KPCB Seed fund

About Investments

Jonathan invests in most industries outside of Consumer. Jonathan often invests in:

Investments

Stages

Pre-seed, Seed, Series A, Series B and beyond

Check Range

$25K-$2M

Geography

US/Canada

Leads Rounds

Sometimes

Investment Highlights

Axle Health, Daybreak Health, OccamzRazor, Osmind, Verifiable

Get in touch

How they work

Affiliated with several funds, including KPCB Seed fund

Contact Links

Please review this investor’s areas of interest, check size, and geographic constraints before making contact: you will have a much higher chance of success if your outreach is targeted.

Disclaimers and footnotes

    Mercury is a fintech company, not an FDIC-insured bank. Banking services provided by Choice Financial Group, Column N.A., and Evolve Bank & Trust, Members FDIC. Deposit insurance covers the failure of an insured bank.